Search all trials

Find therapies in clinical trials near you – page 36

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Endometrial cancer+1

Not recruiting

Registered drugNo placebo

Study of NP137 with carboplatin, paclitaxel and pembrolizumab combination therapy for patients with advanced endometrial or cervical cancer who had prior chemotherapy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Gastric cancer

Not recruiting

Registered drugNo placebo

Study of Spartalizumab combined with FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, docetaxel) for patients with resectable gastric cancer before and after surgery

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Docetaxel

Contact Research Centre

Breast cancer

Not recruiting

Registered drug

Study of Camizestrant and CDK4/6 Inhibitor for Patients with Advanced Breast Cancer with ESR1 Mutation

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Abemaciclib

Contact Research Centre

Pulmonary hypertension

Not recruiting

Investigational

Study on Sotatercept for Treating Pulmonary Hypertension in Adults with Heart Failure

Investigational

France

Participants:18–64 years · 65+ years
Substances:Sotatercept

Contact Research Centre

Lung neoplasm malignant

Not recruiting

InvestigationalNo placebo

Study of Patritumab Deruxtecan for Patients with Previously Treated Metastatic or Locally Advanced EGFR-Mutated Non-Small Cell Lung Cancer

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Patritumab Deruxtecan

Contact Research Centre

Breast cancer female

Not recruiting

Registered drugNo placebo

Study on Chemotherapy and Hormone Therapy for Women Over 70 with ER-Positive, HER2-Negative Breast Cancer Using Cyclophosphamide and Drug Combination

Registered drugNo placebo

France

Participants:65+ years
Substances:Cyclophosphamide

Contact Research Centre

Cardiac amyloidosis

Not recruiting

Investigational

Study on the Effectiveness and Safety of Eplontersen for Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

Investigational

France

Participants:18–64 years · 65+ years
Substances:Eplontersen

Contact Research Centre

Non-small cell lung cancer metastatic

Not recruiting

Investigational

Study on Inupadenant, Carboplatin, and Pemetrexed for Adults with Metastatic Non-Small Cell Lung Cancer After Immunotherapy

Investigational

France

Participants:18–64 years · 65+ years
Substances:Inupadenant Hydrochloride

Contact Research Centre

Interstitial lung disease

Not recruiting

Investigational

Study on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases

Investigational

France

Participants:65+ years
Substances:Bi 1015550

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

Investigational

Study of Sotatercept for Newly Diagnosed Intermediate- and High-risk Pulmonary Arterial Hypertension Patients

Investigational

France

Participants:18–64 years · 65+ years
Substances:Sotatercept

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

InvestigationalNo placebo

Long-term Study of Sotatercept for Adults with Pulmonary Arterial Hypertension (PAH)

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Sotatercept

Contact Research Centre

Soft tissue sarcoma

Not recruiting

Registered drugNo placebo

Study of Nivolumab and Relatlimab for Adults with Advanced or Metastatic Soft-Tissue Sarcoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Find therapies in clinical trials near you – page 36

604 trials match your criteria

Endometrial cancer+1

Study of NP137 with carboplatin, paclitaxel and pembrolizumab combination therapy for patients with advanced endometrial or cervical cancer who had prior chemotherapy

Gastric cancer

Study of Spartalizumab combined with FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, docetaxel) for patients with resectable gastric cancer before and after surgery

Breast cancer

Study of Camizestrant and CDK4/6 Inhibitor for Patients with Advanced Breast Cancer with ESR1 Mutation

Pulmonary hypertension

Study on Sotatercept for Treating Pulmonary Hypertension in Adults with Heart Failure

Lung neoplasm malignant

Study of Patritumab Deruxtecan for Patients with Previously Treated Metastatic or Locally Advanced EGFR-Mutated Non-Small Cell Lung Cancer

Breast cancer female

Study on Chemotherapy and Hormone Therapy for Women Over 70 with ER-Positive, HER2-Negative Breast Cancer Using Cyclophosphamide and Drug Combination

Cardiac amyloidosis

Study on the Effectiveness and Safety of Eplontersen for Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

Non-small cell lung cancer metastatic

Study on Inupadenant, Carboplatin, and Pemetrexed for Adults with Metastatic Non-Small Cell Lung Cancer After Immunotherapy

Interstitial lung disease

Study on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases

Pulmonary arterial hypertension

Study of Sotatercept for Newly Diagnosed Intermediate- and High-risk Pulmonary Arterial Hypertension Patients

Pulmonary arterial hypertension

Long-term Study of Sotatercept for Adults with Pulmonary Arterial Hypertension (PAH)

Soft tissue sarcoma

Study of Nivolumab and Relatlimab for Adults with Advanced or Metastatic Soft-Tissue Sarcoma

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.